Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indicationMarch 19, 2026
Share Facebook Twitter LinkedIn Pinterest Email Raytheon wins $8.41B U.S. Missile Defense Agency modification contract
Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indicationMarch 19, 2026
Europe markets choppy as oil prices soar after fresh attacks on energy infrastructure (EUR:USD:)March 19, 2026